Author

M. Yousefi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Ecology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Approach:statistical model· 2 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

M. M. Winslow· 3 shared C. Li· 2 shared D. A. Petrov· 2 shared G. Boross· 2 shared H. Cai· 2 shared L. Andrejka· 2 shared W.-Y. Lin· 2 shared A. Gaba· 1 shared

Activity by Year

2020-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

M. M. Winslow

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Variability in HIV-1 Transmitted/Founder Virus Susceptibility to Combined APOBEC3F and APOBEC3G Host Restriction

A. Gaba, M. Yousefi, S. Bhattacharjee, L. Chelico

This study investigates how APOBEC3F and APOBEC3G interact to resist HIV-1 Vif-mediated degradation and shows subtype-specific differences in Vif activity against these enzymes.

Journal of Virology · Jan 31, 2025Peer-reviewedMicrobiology

Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma

M. Yousefi, L. Andrejka, M. M. Winslow, D. A. Petrov, G. Boross

This study characterizes the fitness landscapes of tumor suppressor genes in oncogene-negative lung adenocarcinoma, finding that multiple mutations can drive tumor growth with minimal constraints on mutational order.

bioRxiv · Jan 30, 2023Cancer Biology

A Mediterranean-like fat blend protects against the development of severe colitis in the mucin-2 deficient murine model

N. Haskey, J. Ye, M. Estaki, A. Verdugo-Meza, J. A. Barnett, M. Yousefi, B. Birnie, S. Gruenheid, S. Ghosh, D. L. Gibson

The study compares the effects of a Mediterranean-like fat blend to other diets in Muc2-/- mice, finding it reduces colitis severity and promotes beneficial gut microbes.

Gut Microbes · Apr 26, 2022Peer-reviewedImmunology

Combinatorial tumor suppressor inactivation efficiently initiates lung adenocarcinoma with therapeutic vulnerabilities

M. Yousefi, G. Boross, C. Weiss, C. W. Murray, J. D. Hebert, H. Cai, E. L. Ashkin, S. Karmakar, L. Andrejka, L. Chen, M. Wang, M. K. Tsai, W.-Y. Lin, C. Li, P. Yakhchalian, , M. M. Winslow

This study identifies RAS/PI3K pathway activation as a common driver in oncogene-negative lung adenocarcinomas and shows these tumors are vulnerable to targeted therapy.

bioRxiv · Oct 20, 2021Cancer Biology

Developing snakebite risk model using venomous snake habitat suitability as an indicating factor: An application of species distribution models in public health research

M. Yousefi, A. Kafash, A. Khani, N. Nabati

This paper develops a snakebite risk model in Iran using habitat suitability of venomous snakes as an indicator, identifying high-risk areas for public health management.

bioRxiv · Apr 6, 2020Ecology

Quantitative in vivo analyses reveal a complex pharmacogenomic landscape in lung adenocarcinoma

C. Li, W.-Y. Lin, H. Rizvi, H. Cai, C. D. McFarland, Z. N. Rogers, M. Yousefi, I. P. Winters, C. M. Rudin, D. Petrov, M. M. Winslow

The paper uses a quantitative platform and statistical methods to map pharmacogenomic responses in lung cancer, revealing complex genotype-specific therapeutic interactions.

bioRxiv · Jan 28, 2020Cancer Biology